Institut klinické a experimentální mediciny

Institut klinické a experimentální mediciny is a research organisation in Prague 4, Czech Republic that has taken part in 13 EU-funded projects since 2008, receiving €3.2M in EU funding and leading 1 as coordinator.

EU funding received€3.2M
EU projects13
As coordinator1
Running now4
First EU project2008
Latest project2026
CountryCzech Republic
EU registration (PIC)999609154
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institut klinické a experimentální mediciny's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€2.2M · 8 projects
  • Horizon 2020€566k · 3 projects
  • Horizon Europe€349k · 1 project
  • Digital Europe Programme (DIGITAL)€55k · 1 project

Projects

13 EU-funded projects, newest first. Institut klinické a experimentální mediciny led 1 of them as coordinator. Each links to the official record.

  • LiT-MetPartner

    Liver Transplantation for Colorectal Liver Metastases: An International Real-Life Analysis of Post-Transplant Outcomes (LiT-Met)

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €349ktheir share
  • i2XPartner

    i2X – Intelligent Implementations of the European EHR Exchange Format

    Digital Europe Programme (DIGITAL) · 2025–2029 · Project on the EU portal ↗

    €55ktheir share
  • TTV GUIDE TXPartner

    PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €187ktheir share
  • STOPSTORMPartner

    A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE-ENTRANT TACHYCARDIA

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

    €165ktheir share
  • BEAT AFPartner

    Ground-BrEAking Electroporation-based inTervention for Atrial Fibrillation treatment (BEAT AF)

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €214ktheir share
  • EUROSTAMPartner

    A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €213ktheir share
  • BIO-DrIMPartner

    Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €500ktheir share
  • PRIORITYPartner

    Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €65ktheir share
  • BETATRAINPartner

    European Training Network for Excellence in Molecular Imaging in Diabetes

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €214ktheir share
  • MABSOTPartner

    Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €353ktheir share
  • RENAL FUNCTIONS/EETSCoordinator

    Role of Epoxyeicosatrienoic Acids in the Regulation of Blood Pressure, Renal Hemodynamics and Sodium Excretion in Renovascular Model of Hypertension

    FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗

    €75ktheir share
  • ENCITEPartner

    European Network for Cell Imaging and Tracking Expertise

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €494ktheir share
  • DIAdvisorPartner

    Personal Glucose Predictive Diabetes Advisor

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €293ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alkali metals
  • cardiac arrhythmia
  • cells technologies
  • colorectal cancer
  • continuous glucose monitors
  • crisis management
  • dementia
  • diabetes
  • diabetic nephropathy
  • diagnostic imaging
  • enzymes
  • immunology
  • infectious diseases
  • internet of things

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime